GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Cost of Goods Sold

Nanjing Pharmaceutical Co (SHSE:600713) Cost of Goods Sold : ¥50,120 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Cost of Goods Sold?

Nanjing Pharmaceutical Co's cost of goods sold for the three months ended in Mar. 2024 was ¥13,112 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Mar. 2024 was ¥50,120 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nanjing Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 6.03%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Nanjing Pharmaceutical Co's Inventory Turnover for the three months ended in Mar. 2024 was 2.25.


Nanjing Pharmaceutical Co Cost of Goods Sold Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Cost of Goods Sold Chart

Nanjing Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34,698.92 37,286.15 42,185.99 46,962.43 50,276.36

Nanjing Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,268.00 12,438.23 12,377.15 12,192.98 13,111.85

Nanjing Pharmaceutical Co Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥50,120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Pharmaceutical Co  (SHSE:600713) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nanjing Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(13952.545 - 13111.848) / 13952.545
=6.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Nanjing Pharmaceutical Co's Inventory Turnover for the three months ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Nanjing Pharmaceutical Co Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Nanjing Pharmaceutical Co's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Pharmaceutical Co (SHSE:600713) Business Description

Traded in Other Exchanges
N/A
Address
No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Executives
Xiao Hong senior management
Peng Yu Ping senior management
She Ping Supervisors
Jiang Xiao Jun senior management
Teng Xue Wu senior management
Zhou Jian Jun senior management
Li Yi Director
Huang Yan Li Supervisors
Tang Jian Zhong senior management
Zhang Yan Hui senior management
Zhou Yao Ping Director
Wang Hui Qing senior management
He Jin Geng senior management
Ding Feng Jun Director
Liang Yu Tang Director

Nanjing Pharmaceutical Co (SHSE:600713) Headlines

No Headlines